Drug Pipeline

Anti-Thymocyte Globulin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
17
Active Studies
9
Recruiting
10
Top Sponsors
Active Studies by Phase
Phase 2
12
Phase 1/2
3
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03121001 Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive… Sickle Cell Disease Recruiting
NCT05917405 Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults… Acute Myeloid Leukemia in Remission Recruiting
NCT01624805 Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or… Aplastic Anemia Recruiting
NCT06055608 Advancing Transplantation Outcomes in Children Kidney Transplant Recruiting
NCT02727803 Personalized NK Cell Therapy in CBT Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recruiting
NCT04395222 Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation Hematologic Malignancy Active, Not Recruiting
NCT03121014 Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to… Acute Myeloid Leukemia Active, Not Recruiting
NCT00882895 Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin Active, Not Recruiting
NCT05156710 BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) Transplant Rejection Active, Not Recruiting
NCT00716066 Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases Autoimmune Disease Active, Not Recruiting
NCT07216391 Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG Type 1 Diabetes Mellitus Not Yet Recruiting
NCT03849651 TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use… Acute Lymphoblastic Leukemia (ALL) Active, Not Recruiting
Phase 1/2
NCT04224558 Stem Cell Transplantation in Crohn's Disease Crohn Disease Recruiting
NCT07061574 A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent… Type 1 Diabetes Recruiting
NCT03622788 Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following… Acute Lymphoblastic Leukemia Active, Not Recruiting
Phase 1
NCT05757310 A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte… Recurrent Severe Aplastic Anemia Recruiting
NCT07257419 CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted… Relapsed Pediatric ALL Recruiting
Sponsors Running Anti-Thymocyte Globulin Trials
M.D. Anderson Cancer Center (3) University of Illinois at Chicago (2) St. Jude Children's Research Hospital (2) City of Hope Medical Center (2) Fred Hutchinson Cancer Center (1) Washington University School of Medicine (1) Cedars-Sinai Medical Center (1) Weill Medical College of Cornell University (1) Sanofi (1) Nantes University Hospital (1)
Disease Areas
Myelodysplastic Syndromes (MDS) (5) Leukemia (5) Acute Myeloid Leukemia (AML) (5) Acute Lymphoblastic Leukemia (ALL) (4) Non-Hodgkin Lymphoma (3) Hodgkin Lymphoma (3) Multiple Myeloma (2) Myelofibrosis (2) Type 1 Diabetes (2) Diabetes (2)
Get alerts when Anti-Thymocyte Globulin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free